Joint Site and Sponsor Perspectives on Innovative Solutions Addressing Sites Challenges
Update: 2025-07-21
Description
Summary:
In this session, pharma sponsors and sites gather to present innovative solutions to solve site challenges in workforce and capability gaps, increasing technology burden, patient enrollment and managing clinical trial protocol complexity. They discuss efforts to address those challenges, early impacts and outcomes.
In this panel:
This panel was recorded at the 2024 DPHARM: Disruptive Innovations to Advance Clinical Research. For more information about the 2025 DPHARM, visit DPHARMconference.com.
In this session, pharma sponsors and sites gather to present innovative solutions to solve site challenges in workforce and capability gaps, increasing technology burden, patient enrollment and managing clinical trial protocol complexity. They discuss efforts to address those challenges, early impacts and outcomes.
In this panel:
- Dennis Salotti, MS, MBA, Executive Director & Head of Clinical Outsourcing & Innovation, Jazz Pharmaceuticals
- Kristin Herman, Executive Director, Clinical Trials Office, Sidney Kimmel Cancer Center, Jefferson Health
- Eileen Hughes, RN, BS, Senior Manager, Site Partnerships, CSL Behring
- Lisa Kiehne, SVP, Operations, The START Center for Cancer Research
- Christopher McNair, PhD, Associate Director, Data Science and Cancer Informatics, Sidney Kimmel Cancer Center, Jefferson Health
- Tracey Robertson, Head of Patient and Site Engagement Capability Management, Boehringer Ingelheim
This panel was recorded at the 2024 DPHARM: Disruptive Innovations to Advance Clinical Research. For more information about the 2025 DPHARM, visit DPHARMconference.com.
Comments
In Channel